This filing is purely administrative and does not affect the company's financial position or outlook. Traders should focus on upcoming clinical data readouts or pipeline updates for material catalysts.
Price Chart
Executive Summary
Adicet Bio filed an amended 10-K/A to correct an inadvertent omission in Item 9A — the original filing lacked a statement on the effectiveness conclusions of disclosure controls and procedures. The amendment adds management's conclusion that controls were effective as of December 31, 2025. No financial restatements, auditor changes, or material operational updates are included.
Key Facts
- Amendment solely corrects an omission in Item 9A regarding disclosure controls and procedures.
- CEO and CFO concluded disclosure controls and procedures were effective as of December 31, 2025.
- No changes to financial statements, auditor opinion, or any other sections of the original 10-K.
- Original 10-K was filed March 12, 2026; this amendment filed May 20, 2026.
Financial Impact
No financial impact; administrative correction only.
Risk Factors
- No new risks identified from this filing; risks remain as disclosed in the original 10-K.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-K/A Filing (Primary) | 0001720580-26-000042 |
| Document: acet-ex31_1.htm | 0001720580-26-000042 |
| Document: acet-ex31_2.htm | 0001720580-26-000042 |
| Document: 0001720580-26-000042-index-headers.html | 0001720580-26-000042 |
| Document: 0001720580-26-000042-index.html | 0001720580-26-000042 |
| Document: 0001720580-26-000042.txt | 0001720580-26-000042 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 2d ago | SC 13G | $4.03 | awaiting T+5 | — | $4.05 (+0.64%) |
Sep 28, 2026 28d ago | 8-K | $6.35 $6.47 | ▲ +1.89% | ▲ +0.69% | $4.05 (−36.14%) |
Sep 1, 2026 7w ago | 8-K | $9.26 $9.54 | ▲ +3.02% | ▲ +2.94% | $4.05 (−56.21%) |
May 20, 2026 22w ago | 10-K/A | $7.89 $9.31 | ▲ +18.00% | ▲ +16.15% | $4.05 (−48.61%) |
May 13, 2026 23w ago | 8-K | $8.41 $7.89 | ▼ −6.18% | ▼ −5.47% | $4.05 (−51.78%) |
Apr 8, 2026 28w ago | 144 | $6.86 $8.05 | ▲ +17.35% | ▲ +14.16% | $4.05 (−40.89%) |
Apr 7, 2026 28w ago | 144 | $6.55 $7.92 | ▲ +20.92% | ▲ +17.40% | $4.05 (−38.09%) |
Mar 24, 2026 30w ago | EFFECT | $6.69 $6.81 | ▲ +1.79% | ▲ +2.22% | $4.05 (−39.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers